Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Preventing Excessive Weight Gain and Maternal and Infant Fat Accretion

NCT04868110
unknownnot_applicable

Dietary Fiber, Microbiota and Cognitive Function in Healthy Adults

NCT04951674
completedphase_2

Low Glycemic Index Diet (With Canola Oil) for Type 2 Diabetics

NCT01348568
completednot_applicable

Cancer Dietary Objectives Study

NCT00561977

Clinical Trials (4)

Showing 4 of 4 trials
NCT04868110Not Applicable

Preventing Excessive Weight Gain and Maternal and Infant Fat Accretion

Completed
NCT04951674Not Applicable

Dietary Fiber, Microbiota and Cognitive Function in Healthy Adults

Unknown
NCT01348568Phase 2

Low Glycemic Index Diet (With Canola Oil) for Type 2 Diabetics

Completed
NCT00561977Not Applicable

Cancer Dietary Objectives Study

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4